Gut Microbiome in Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Kyunghee University Medical Center
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Age range not stated in the record
- Any sex
Some of the main requirements, copied from the record:
- Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 1500 participants are expected to take part.
- Start date: 2018-04-01.
- Main results expected around 2028-03-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in South Korea.
Main thing being measured
- Composition and diversity of gut microbiome (Up to 10 years)
In the researchers’ words
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease |
| Lead sponsor | Kyunghee University Medical Center |
| Enrollment | 1500 (estimated) |
| Start date | 2018-04-01 |
| Primary completion (est.) | 2028-03-31 |
| First posted | 2018-07-17 |
| Last updated | 2023-03-10 |
| Official title | Discovery of Gut Microbial Signatures in Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT03589183 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease Exclusion Criteria: * Person with history of using antibiotics or probiotics within previous 2 weeks.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Kyung Hee University Hospital | Seoul | South Korea | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.